|

- 积分
- 1
- 威望
- 1
- 包包
- 292
|
When Nature broke the news in December 2011 that Novartis
7 o9 ?3 M$ H/ x! mwas to close its brain research facility in Basel, Switzerland,
6 R) J5 b0 | r. bthe story noted that this move closely followed similar cuts5 o, o: m9 R; ~6 d8 P
by rival pharmaceutical firms. As a report from the European College
$ d7 p6 L b9 h$ @! |6 m- |# x4 aof Neuropsychopharmacology
3 b/ r( \+ T& chad warned a few months earlier, the1 n6 n: z- b9 W+ S9 ~
abandonment of research into new psychiatric drugs by AstraZeneca,4 X: A% s s( |! D8 J2 O* p
GlaxoSmithKline
) Q1 D( ^( A' y! o* S. yand others meant that “withdrawal of research
1 N0 ~6 v3 F& A* m" D) t! l* qresources is a withdrawal of hope for patients and their families”.
' ]9 Z; L1 Q* ]
9 l0 G/ @5 J: ?, _8 Y- H" d1 p' A* H4 ~5 Q \. \) r# B& k
回复有免费下载链接, p2 t5 t4 T3 m/ H6 i' \
3 N3 a+ J9 F5 w# X8 F |
-
总评分: 包包 + 20
查看全部评分
|